Staley Capital Advisers Inc. Boosts Holdings in Corteva, Inc. $CTVA

Staley Capital Advisers Inc. boosted its stake in Corteva, Inc. (NYSE:CTVA) by 1.9% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 554,074 shares of the company’s stock after acquiring an additional 10,331 shares during the period. Corteva comprises approximately 2.0% of Staley Capital Advisers Inc.’s portfolio, making the stock its 18th largest position. Staley Capital Advisers Inc. owned approximately 0.08% of Corteva worth $46,382,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of the stock. Drummond Knight Asset Management Pty Ltd acquired a new stake in shares of Corteva in the fourth quarter valued at approximately $25,713,000. Avior Wealth Management LLC increased its holdings in shares of Corteva by 464.7% in the 4th quarter. Avior Wealth Management LLC now owns 32,901 shares of the company’s stock valued at $2,205,000 after acquiring an additional 27,075 shares during the period. Arbejdsmarkedets Tillaegspension acquired a new position in shares of Corteva in the 4th quarter valued at $23,679,000. Squarepoint Ops LLC raised its position in Corteva by 423.6% in the 3rd quarter. Squarepoint Ops LLC now owns 1,738,139 shares of the company’s stock valued at $117,550,000 after purchasing an additional 1,406,199 shares during the last quarter. Finally, Leonteq Securities AG purchased a new stake in Corteva in the 4th quarter valued at $2,350,000. Institutional investors and hedge funds own 81.54% of the company’s stock.

Corteva Stock Down 1.8%

CTVA stock opened at $85.21 on Thursday. The stock has a market capitalization of $56.99 billion, a PE ratio of 50.12, a price-to-earnings-growth ratio of 2.65 and a beta of 0.56. The company has a fifty day moving average of $80.19 and a 200-day moving average of $77.36. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.03 and a current ratio of 1.47. Corteva, Inc. has a one year low of $60.53 and a one year high of $87.69.

Corteva (NYSE:CTVA) last issued its quarterly earnings results on Tuesday, May 5th. The company reported $1.50 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.18 by $0.32. The business had revenue of $4.91 billion for the quarter, compared to analyst estimates of $4.64 billion. Corteva had a net margin of 6.50% and a return on equity of 9.95%. The business’s revenue was up 11.0% compared to the same quarter last year. During the same period in the previous year, the business posted $1.13 earnings per share. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. As a group, analysts expect that Corteva, Inc. will post 3.72 EPS for the current year.

Corteva Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, June 15th. Stockholders of record on Monday, June 1st were paid a dividend of $0.18 per share. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date of this dividend was Monday, June 1st. Corteva’s dividend payout ratio is 42.35%.

Analyst Ratings Changes

Several brokerages have issued reports on CTVA. Berenberg Bank raised their price objective on shares of Corteva from $68.00 to $78.00 and gave the stock a “hold” rating in a research report on Thursday, March 26th. Barclays upped their target price on shares of Corteva from $84.00 to $91.00 and gave the company an “overweight” rating in a report on Thursday, June 11th. BNP Paribas Exane increased their target price on shares of Corteva from $74.00 to $77.00 in a research note on Wednesday, May 6th. Rothschild & Co Redburn raised their price target on Corteva from $80.00 to $90.00 and gave the stock a “neutral” rating in a report on Wednesday, April 29th. Finally, Deutsche Bank Aktiengesellschaft boosted their price target on Corteva from $90.00 to $100.00 in a research report on Monday, May 11th. Thirteen analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $88.90.

Corteva Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.